The Study on the Use of "UniLine" Bioprosthesis in the Treatment of Isolated Aortic and Mitral Valve Diseases

Recruiting Observational Study
Aortic Valve Disease Mitral Valve Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Closed Joint-Stock Company NeoCor · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this open, prospective, multicenter study is analyze long-term outcomes of aortic/mitral valve replacement using the "UniLine" bioprosthesis in patients with acquired aortic or mitral valve diseases. Main research objectives: To analyze long-term (up to 12 years) outcome of aortic or mitral valve replacement using the "UniLine" bioprosthesis. To study the hemodynamic characteristics…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Provided informed consent to participate in the study. 2. Must be aged 18 years and older. 3. Patients with isolated acquired mitral or aortic valve disease. 4. No prior heart valve replacement, current replacement must be planned (not conducted in an urgent/ emergency manner…
Contacts

Evgeny Bazdyrev, MD, PhD

+7-3842-64-42-40

clinicresearch@kemcardio.ru

CONTACT

Michael Karelin

8 (913) 433 7669

karelin@ctmedical.ru

CONTACT